Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Quest Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Quest Diagnostics Inc, Medical Devices Deals, 2011 to YTD 2017 10
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Quest Diagnostics Acquires Lab Outreach Service Business of Clinical Laboratory Partners 13
Quest Diagnostics Acquires Lab Outreach Service Business from Memorial Care Health System 14
Quest Diagnostics Acquires Outreach Laboratory Service Operations from Steward Health Care System 15
Quest Diagnostics Completes Acquisition Of Lab-Related Clinical Outreach Operations Of Dignity Health 16
Quest Diagnostics Acquires Advanced Toxicology Network Lab Business Of Concentra Operating 18
Quest Diagnostics Completes Acquisition Of Clinical Outreach Lab Business Of UMass Memorial Medical Center 19
Partnerships 20
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 20
Quintiles to Form Joint Venture with Quest Diagnostics 22
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 23
Quest Diagnostics Enters Into Collaboration With Genomic Vision 24
Licensing Agreements 25
TrovaGene Enters Into Licensing Agreement With Quest Diagnostics For NPM1 Marker 25
Debt Offering 26
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 26
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 28
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 30
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 32
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 33
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2040 For US$200 Million 34
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2014 For US$200 Million 35
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2016 For US$300 Million 36
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2021 For US$550 Million 37
Asset Transactions 38
Royalty Pharma Acquires Ibrutinib Royalty Rights From Quest Diagnostics For US$485 Million 38
Acquisition 39
Quest Diagnostics May Sell itself 39
Quest Diagnostics Completes Acquisition Of Summit Health, Prevention And Wellness Service Provider 40
Quest Diagnostics Completes Acquisition Of Solstas Lab Partners From Welsh, Carson, Anderson & Stowe For US$570 Million 41
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 42
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 43
Quest Diagnostics Completes Acquisition Of Celera 44
Quest Diagnostics Completes Acquisition Of Athena Diagnostics 46
Quest Diagnostics Inc – Key Competitors 48
Quest Diagnostics Inc – Key Employees 49
Quest Diagnostics Inc – Locations And Subsidiaries 51
Head Office 51
Other Locations & Subsidiaries 51
Joint Venture 53
Recent Developments 54
Financial Announcements 54
Oct 19, 2017: Quest Diagnostics Reports Third Quarter 2017 Financial Results 54
Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook 55
Apr 20, 2017: Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook 56
Jan 26, 2017: Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017 57
Nov 11, 2016: Quest Diagnostics Raises Revenue Growth Outlook, Increases Dividend at 2016 Investor Day 58
Oct 20, 2016: Quest Diagnostics Reports Third Quarter 2016 Financial Results 59
Jul 21, 2016: Quest Diagnostics Reports Second Quarter 2016 Financial Results 61
Apr 21, 2016: Quest Diagnostics Reports First Quarter 2016 Financial Results 63
Jan 28, 2016: Quest Diagnostics Reports Fourth Quarter And Full Year 2015 Financial Results; Provides Guidance For Full Year 2016; Increases Dividend 5% To $0.40 Per Quarter 64
Corporate Communications 65
Mar 06, 2017: Quest Diagnostics and American Diabetes Association to Help Identify People at Risk for Type 2 Diabetes 65
Dec 15, 2016: Quest Diagnostics Board of Directors Elects Stephen H. Rusckowski Chairman of the Board 66
Legal and Regulatory 67
Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 67
Government and Public Interest 68
Nov 20, 2017: Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests 68
Sep 06, 2017: Half of Americans Tested Misuse Their Prescription Medications, According to Quest Diagnostics Analysis 69
Other Significant Developments 71
Sep 27, 2017: Quest Diagnostics Provides Update On Impact to Third Quarter Financial Results from Hurricanes 71
Oct 18, 2016: IBM and Quest Diagnostics Launch Watson-Powered Genomic Sequencing Service to Help Physicians Bring Precision Cancer Treatments to Patients Nationwide 72
Appendix 74
Methodology 74
About GlobalData 74
Contact Us 74
Disclaimer 74
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Quest Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Quest Diagnostics Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Quest Diagnostics Inc, Medical Devices Deals, 2011 to YTD 2017 10
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Quest Diagnostics Acquires Lab Outreach Service Business of Clinical Laboratory Partners 13
Quest Diagnostics Acquires Lab Outreach Service Business from Memorial Care Health System 14
Quest Diagnostics Acquires Outreach Laboratory Service Operations from Steward Health Care System 15
Quest Diagnostics Completes Acquisition Of Lab-Related Clinical Outreach Operations Of Dignity Health 16
Quest Diagnostics Acquires Advanced Toxicology Network Lab Business Of Concentra Operating 18
Quest Diagnostics Completes Acquisition Of Clinical Outreach Lab Business Of UMass Memorial Medical Center 19
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 20
Quintiles to Form Joint Venture with Quest Diagnostics 22
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 23
Quest Diagnostics Enters Into Collaboration With Genomic Vision 24
TrovaGene Enters Into Licensing Agreement With Quest Diagnostics For NPM1 Marker 25
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 26
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 28
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 30
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 32
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 33
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2040 For US$200 Million 34
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2014 For US$200 Million 35
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2016 For US$300 Million 36
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2021 For US$550 Million 37
Royalty Pharma Acquires Ibrutinib Royalty Rights From Quest Diagnostics For US$485 Million 38
Quest Diagnostics May Sell itself 39
Quest Diagnostics Completes Acquisition Of Summit Health, Prevention And Wellness Service Provider 40
Quest Diagnostics Completes Acquisition Of Solstas Lab Partners From Welsh, Carson, Anderson & Stowe For US$570 Million 41
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 42
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 43
Quest Diagnostics Completes Acquisition Of Celera 44
Quest Diagnostics Completes Acquisition Of Athena Diagnostics 46
Quest Diagnostics Inc, Key Competitors 48
Quest Diagnostics Inc, Key Employees 49
Quest Diagnostics Inc, Subsidiaries 51
Quest Diagnostics Inc, Joint Venture 53